8-KRegulation FD

UNITEDHEALTH GROUP INC 8-K Report, Regulation FD Disclosure (Mar 10, 2017)

Filed March 10, 2017For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) filed an 8-K on March 10, 2017, primarily to announce upcoming participation in the Barclays Global Healthcare Conference. Senior leadership is scheduled to discuss key aspects of the company's business, including its strategic direction, competitive standing in the market, capital allocation strategies, recent financial performance, and anticipated shifts in its operating environments.

Key Highlights

  • 1UnitedHealth Group leadership will participate in the Barclays Global Healthcare Conference on March 14, 2017.
  • 2The discussion will cover the company's strategy and market positions.
  • 3Information regarding the use of capital by UNH will be shared.
  • 4Recent financial results will be addressed during the conference.
  • 5Expectations for changes in UNH's end markets will be a topic of discussion.
  • 6A live audio webcast of the presentation will be available on the company's investor website.

Frequently Asked Questions

The primary purpose of this 8-K filing is to inform investors about UnitedHealth Group's participation in the Barclays Global Healthcare Conference and to announce that senior leadership will be available to discuss various aspects of the company's business.

The presentation is scheduled for Tuesday, March 14, 2017, at 10:45 a.m. Eastern Time, and will take place at the Barclays Global Healthcare Conference in Miami, Florida.

A live audio webcast of the presentation will be made available on the Investors page of UnitedHealth Group's website, www.unitedhealthgroup.com.

The presentation will cover the company's strategy, market positions, use of capital, recent results, and expectations for changes in its end markets.